Clinical Trial Update: Zimberelimab Plus Lenvatinib After Progression on Prior Immune Checkpoint Inhibitors for Advanced Cervical Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating zimberelimab plus lenvatinib in advanced cervical cancer patients who progressed on prior immune checkpoint inhibitors; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• LENVIMA (lenvatinib)
• Zimberelimab (zimberelimab)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Cervical Cancer, Cervical Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING